Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
ProQR Therapeutics
PRQR
$271M
| $547K | ﹤0.01% |
+604,181
| New | +$2.02M |
|
3127
Paymentus
PAY
$5.32B
| $546K | ﹤0.01% |
+25,900
| New | +$639K |
|
|
PPTA
3128
Perpetua Resources
PPTA
$3.16B
| $546K | ﹤0.01% |
133,100
+110,300
| +484% | +$441K |
|
3129
Moog Inc Class B
MOG.B
| $545K | ﹤0.01% |
6,100
| – | – |
|
3130
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.3B
| $545K | ﹤0.01% |
3,100
-1,700
| -35% | -$296K |
|
3131
Globus Maritime Ltd
GLBS
$78.1M
| $544K | ﹤0.01% |
235,499
+207,259
| +734% | +$432K |
|
|
CYXT
3132
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $544K | ﹤0.01% |
+44,500
| New | +$523K |
|
3133
Nerdy
NRDY
$92M
| $542K | ﹤0.01% |
106,500
+75,300
| +241% | +$336K |
|
3134
Caledonia Mining Corp
CMCL
$434M
| $541K | ﹤0.01% |
35,565
+5,065
| +17% | +$63.8K |
|
|
MTL.PR
3135
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $541K | ﹤0.01% |
898,438
-51,500
| -5% | -$98.1K |
|
3136
Allegro MicroSystems
ALGM
$8.26B
| $540K | ﹤0.01% |
+19,000
| New | +$543K |
|
3137
Nomura Holdings
NMR
$28.7B
| $539K | ﹤0.01% |
127,690
-74,600
| -37% | -$337K |
|
|
EXK
3138
Endeavour Silver
EXK
$3.15B
| $538K | ﹤0.01% |
115,800
-249,700
| -68% | -$1.09M |
|
|
ONL
3139
Orion Office REIT
ONL
$164M
| $538K | ﹤0.01% |
+38,400
| New | +$647K |
|
3140
GT Biopharma
GTBP
$10.7M
| $537K | ﹤0.01% |
6,210
-4,013
| -39% | -$354K |
|
|
NEXN
3141
Nexxen International
NEXN
$585M
| $537K | ﹤0.01% |
35,300
-26,000
| -42% | -$375K |
|
3142
Cadiz
CDZI
$293M
| $536K | ﹤0.01% |
+258,900
| New | +$652K |
|
|
CBIO
3143
Crescent Biopharma
CBIO
$637M
| $536K | ﹤0.01% |
4,706
-1,307
| -22% | -$153K |
|
3144
Kopin
KOPN
$993M
| $536K | ﹤0.01% |
211,964
-10,800
| -5% | -$31.1K |
|
3145
VirTra
VTSI
$37M
| $536K | ﹤0.01% |
87,800
-23,100
| -21% | -$143K |
|
|
DMTK
3146
DELISTED
DermTech, Inc. Common Stock
DMTK
| $536K | ﹤0.01% |
+36,500
| New | +$488K |
|
|
ARAV
3147
DELISTED
Aravive, Inc. Common Stock
ARAV
| $536K | ﹤0.01% |
277,829
-64,500
| -19% | -$139K |
|
|
CLEU
3148
DELISTED
China Liberal Education Holdings
CLEU
| $534K | ﹤0.01% |
+21
| New | +$393K |
|
|
LND
3149
BrasilAgro
LND
$354M
| $533K | ﹤0.01% |
78,900
+48,100
| +156% | +$284K |
|
|
GBIO
3150
DELISTED
Generation Bio
GBIO
| $532K | ﹤0.01% |
7,250
-15,640
| -68% | -$906K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.